Power and water utilities have historically serviced equipment on fixed schedules regardless of actual condition. Digital twins fed by live sensor data are letting them switch to condition-based maintenance — and the shift changes which failures get caught before they happen.
Every iPhone sold in the US since the iPhone 14 has shipped without a physical SIM slot. The eSIM pitch was that switching carriers would get easier. For a meaningful share of real transfers, it has gotten harder.
Restaking let one pool of staked ether secure dozens of unrelated services at once. That solved a real capital-efficiency problem — and created a new one: a single operator fault can now cascade across protocols that have nothing to do with each other.
A pipeline running from automaker telematics and phone apps to data brokers like LexisNexis and Verisk feeds driver-behavior scores straight into insurance rates — with uneven state-by-state protection and no requirement to disclose what drove your premium.
DRAM contract prices have jumped 50-95% in a single quarter as AI clusters absorb memory manufacturing capacity once reserved for PCs. Here's what that means for your next purchase.
Frontier AI benchmarks are clustering near the ceiling, turning leaderboard rank into statistical noise — and the gap between lab scores and real-world deployment performance is the number that actually matters now.
Automated playtesting tools from Unity, Modl.ai, and in-house studio teams are cutting QA headcount on content-heavy live-service games — but only on the repetitive half of the job.
ReMarkable, Kindle Scribe, and Boox have quietly repositioned e-ink devices from a reading niche into a $300-700 productivity category aimed at paper, not e-readers.
Falcon 9, New Glenn, and Neutron all reuse their first stage and throw away the second. That expendable upper stage, not the booster, is now the real floor under launch costs.
Carbon Robotics says its LaserWeeders have eliminated 35 billion weeds across 15 countries. The technology works. The layoffs show the business model is still catching up to the engineering.
Carta data shows the overall down-round rate fell in 2026. The real story is a split: frontier labs and infrastructure startups command record premiums while 2023-era application startups get quietly repriced or absorbed.
Generate Biomedicines has an AI-designed antibody in multiple Phase III asthma trials. Isomorphic Labs and Xaira are close behind. Here is what actually separates hype from a filed IND.